English
Back
Download
Log in to access Online Inquiry
Back to the Top

$TERN

$TERN
$TERN
There is a catalyst for GLP-1 in the second quarter.
A new design that can be administered orally from a syringe.
Obesity-related.
I think it will rise similarly to IBRX and ALT.
$TERN
Let's meet at $15👋
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
13
+0
See Original
Report
8955 Views
Comment
Sign in to post a comment
    すなっちゃんコミュニティホームページ→https://snatchan.online/ 米国株投資歴11年 米国株スイング、デイトレ、オプションメ
    236
    Followers
    5
    Following
    756
    Visitors
    Follow